Profil
Stacy Price is currently Chief Technology Officer at Upstream Bio, Inc. since 2025.
Former positions include Senior Vice President-Technical Operations at Alaunos Therapeutics, Inc., Chief Technical Officer at Akouos, Inc. from 2021 to 2022, and Chief Technology & Manufacturing Officer at Invivyd, Inc. from 2023 to 2024.
Education includes undergraduate and graduate degrees from Tufts University.
Postes actifs de Stacy Price
| Sociétés | Poste | Début |
|---|---|---|
| UPSTREAM BIO, INC. | Directeur Technique/Scientifique/R&D | 20/05/2025 |
Anciens postes connus de Stacy Price
| Sociétés | Poste | Fin |
|---|---|---|
| INVIVYD, INC. | Directeur Technique/Scientifique/R&D | 18/11/2024 |
| AKOUOS | Directeur Technique/Scientifique/R&D | 01/12/2022 |
| ALAUNOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Stacy Price
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Akouos, Inc.
Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Invivyd, Inc.
Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Upstream Bio, Inc.
Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
















